Research advances on growth factors and cytokines in wound repair

doi:10.3877/cma.j.issn.1673-9450.2023.02.014

Abstract

Abstract:

Wound repair is a complex process involving a variety of cells, which achieve tissue and epithelial regeneration via cell migration, proliferation and differentiation. These complex physiological and biochemical reactions are regulated by cell signal transduction. Cells involved in wound repair will secrete some growth factors or cytokines, and these factors will participate in the signal pathway regulating wound healing to promote wound healing. The application of growth factors in wound treatment is still a hot topic. This article reviews the research of growth factors and cytokines in the process of wound repair.

Key words: Growth factor, Cytokines, Wound repair

Fang Li, Quan Li, Shengjun Cao, Lingfeng Wang. Research advances on growth factors and cytokines in wound repair[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2023, 18(02): 174-179.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhssyxfzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1673-9450.2023.02.014

https://zhssyxfzz.cma-cmc.com.cn/EN/Y2023/V18/I02/174

References 51

[1]	Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation[J]. Sci Transl Med, 2014, 6(265): 265sr6.
[2]	Julie K, Nguyen, et al. The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets[J]. Arch Dermatol Res, 2020, 312(2): 81-92.
[3]	Salmon-Ehr V, Ramont L, Godeau G, et al. Implication of interleukin-4 in wound healing[J]. Lab Invest, 2000, 80(8)：1337-1343.
[4]	Xiao S, Huang G, Wei Z, et al. IL-10 gene-modified human amniotic mesenchymal stem cells augment regenerative wound healing by multiple synergistic effects[J]. Stem Cells Int, 2019, 2019: 9158016.
[5]	Wang Y, Bai Y, Li Y, et al. IL-15 enhances activation and IGF-1 production of dendritic epidermal T cells to promote wound healing in diabetic mice[J]. Front Immunol, 2017, 24(8): 1557.
[6]	Lee J, Rodero MP, Patel J, et al. Interleukin-23 regulates interleukin-17 expression in wounds, and its inhibition accelerates diabetic wound healing through the alteration of macrophage polarization[J]. FASEB J, 2018, 32(4): 2086-2094.
[7]	Groves RW, Schmidt-Lucke JA. Recombinant human GM-CSF in the treatment of poorly healing wounds[J]. Adv Skin Wound Care, 2000, 13(3): 107-112.
[8]	Rho CR, Park MY, Kang S. Effects of granulocyte-macrophage colony-stimulating (GM-CSF) factor on corneal epithelial cells in corneal wound healing model[J]. PLoS One, 2015, 10(9): e0138020.
[9]	Mann A, Breuhahn K, Schirmacher P, et al. Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization[J]. J Invest Dermatol, 2001, 117(6): 1382-1390.
[10]	Mann A, Niekisch K, Schirmacher P, et al. Granulocyte-macrophage colony-stimulating factor is essential for normal wound healing[J]. J Investig Dermatol Symp Proc, 2006, 11(1): 87-92.
[11]	Fang Y, Gong SJ, Xu YH, et al. Impaired cutaneous wound healing in granulocyte/macrophage colony-stimulating factor knockout mice[J]. Br J Dermatol, 2007, 157(3): 458-465.
[12]	Fang Y, Shen J, Yao M, et al. Granulocyte-macrophage colony-stimulating factor enhances wound healing in diabetes via upregulation of proinflammatory cytokines[J]. Br J Dermatol, 2010, 162(3): 478-486.
[13]	Castro-Dopico T, Fleming A, Dennison TW, et al. GM-CSF calibrates macrophage defense and wound healing programs during intestinal infection and inflammation[J]. Cell Rep, 2020, 32(1): 107857.
[14]	Hu X, Sun H, Han C, et al. Topically applied rhGM-CSF for the wound healing: a systematic review[J]. Burns, 2011, 37(5): 729-741.
[15]	Barrientos S, Brem H, Stojadinovic O, et al. Clinical application of growth factors and cytokines in wound healing[J]. Wound Repair Regen, 2014, 22(5): 569-578.
[16]	Galiano RD, Tepper OM, Pelo CR, et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells[J]. Am J Pathol, 2004, 164(6): 1935-1947.
[17]	Gopalakrishnan A, Ram M, Kumawat S, et al. Quercetin accelerated cutaneous wound healing in rats by increasing levels of VEGF and TGF-β1[J]. Indian J Exp Biol, 2016, 54(3): 187-195.
[18]	Zhou J, Ni M, Liu X, et al. Curcumol promotes vascular endothelial growth factor (VEGF)-mediated diabetic wound healing in streptozotocin-induced hyperglycemic rats[J]. Med Sci Monit, 2017, 23: 555-562.
[19]	Liu C, Hao Y, Huang J, et al. Ghrelin accelerates wound healing in combined radiation and wound injury in mice[J]. Exp Dermatol, 2017, 26(2): 186-193.
[20]	Boyar V. Association of systemic or intravitreal antivascular endothelial growth factor (Anti-VEGF) and impaired wound healing in pediatric patients: collagen to the rescue[J]. J Wound Ostomy Continence Nurs, 2021, 48(3): 256-261.
[21]	Nagy JA, Vasile E, Feng D, et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis[J]. J Exp Med, 2002, 196(11): 1497-1506.
[22]	Hirakawa S, Kodama S, Kunstfeld R, et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis[J]. J Exp Med, 2005, 201(7): 1089-1099.
[23]	Koike Y, Yozaki M, Utani A, et al. Fibroblast growth factor 2 accelerates the epithelial-mesenchymal transition in keratinocytes during wound healing process[J]. Sci Rep, 2020, 10(1): 18545.
[24]	Kinoda J, Ishihara M, Nakamura S, et al. Protective effect of FGF-2 and low-molecular-weight heparin/protamine nanoparticles on radiation-induced healing-impaired wound repair in rats[J]. J Radiat Res, 2018, 59(1): 27-34.
[25]	Andres C, Hasenauer J, Ahn HS, et al. Wound-healing growth factor, basic FGF, induces Erk1/2-dependent mechanical hyperalgesia[J]. Pain, 2013, 154(10): 2216-2226.
[26]	Wu J, Zhu J, He C, et al. Comparative study of heparin-poloxamer hydrogel modified bFGF and aFGF for in vivo wound healing efficiency[J]. ACS Appl Mater Interfaces, 2016, 8(29): 18710-18721.
[27]	Peng Y, Wu S, Tang Q, et al. KGF-1 accelerates wound contraction through the TGF-beta1/Smad signaling pathway in a double-paracrine manner[J]. J Biol Chem, 2019, 294(21): 8361-8370.
[28]	Xiaojie W, Banda J, Qi H, et al. Scarless wound healing: current insights from the perspectives of TGF-β，KGF-1, and KGF-2[J]. Cytokine Growth Factor Rev, 2022, 66: 26-37.
[29]	Watson J, Francavilla C. Regulation of FGF10 signaling in development and disease[J]. Front Genet, 2018, 9: 500.
[30]	Xu K, Chai B, Zhang K, et al. Topical application of fibroblast growth factor 10-PLGA microsphere accelerates wound healing via inhibition of ER stress[J]. Oxid Med Cell Longev, 2020, 2020: 8586314.
[31]	Oh JS, Lee EJ. Engineered dressing of hybrid chitosan-silica for effective delivery of keratin growth factor and acceleration of wound healing[J]. Mater Sci Eng C Mater Biol Appl, 2019, 103: 109815.
[32]	Bienert M, Hoss M, Bartneck M, et al. Growth factor-functionalized silk membranes support wound healing in vitro[J]. Biomed Mater, 2017, 12(4): 045023.
[33]	Pan H, Shi C, Yang R, et al. Controlled release of KGF-2 for regulation of wound healing by KGF-2 complexed with "lotus seedpod surface-like" porous microspheres[J]. J Mater Chem B, 2021, 9(19): 4039-4049.
[34]	Kaltalioglu K, Coskun-Cevher S. A bioactive molecule in a complex wound healing process: platelet-derived growth factor[J]. Int J Dermatol, 2015, 54(8): 972-977.
[35]	Wu LW, Chen WL, Huang SM, et al. Platelet-derived growth factor-AA is a substantial factor in the ability of adipose-derived stem cells and endothelial progenitor cells to enhance wound healing [J]. FASEB J, 2019, 33(2): 2388-2395.
[36]	Shi R, Lian W, Han S, et al. Nanosphere-mediated co-delivery of VEGF-A and PDGF-B genes for accelerating diabetic foot ulcers healing in rats[J]. Gene Ther, 2018, 25(6): 425-438.
[37]	Di Santo MC, Alaimo A, Acebedo SL, et al. Biological responses induced by high molecular weight chitosan administrated jointly with platelet-derived growth factors in different mammalian cell lines [J]. Int J Biol Macromol, 2020, 158: 953-967.
[38]	Mulder G, Tallis AJ, Marshall VT, et al. Treatment of nonhealing diabetic foot ulcers with a platelet-derived growth factor gene-activated matrix (GAM501): results of a phase 1/2 trial[J]. Wound Repair Regen, 2009, 17(6): 772-779.
[39]	Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and cytokines in wound healing[J]. Wound Repair Regen, 2008, 16(5): 585-601.
[40]	Choi SM, Lee KM, Kim HJ, et al. Effects of structurally stabilized EGF and bFGF on wound healing in type I and type II diabetic mice[J]. Acta Biomater, 2018, 66: 325-334.
[41]	Yoon D, Yoon D, Cha HJ, et al. Enhancement of wound healing efficiency mediated by artificial dermis functionalized with EGF or NRG1[J]. Biomed Mater, 2018, 13(4): 045007.
[42]	Qiang W, Zhou T, Lan X, et al. A new nanoscale transdermal drug delivery system: oil body-linked oleosin-hEGF improves skin regeneration to accelerate wound healing[J]. J Nanobiotechnology, 2018, 16(1): 62.
[43]	Dao DT, Anez-Bustillos L, Adam RM, et al. Heparin-binding epidermal growth factor-like growth factor as a critical mediator of tissue repair and regeneration[J]. Am J Pathol, 2018, 188(11): 2446-2456.
[44]	Penn JW, Grobbelaar AO, Rolfe KJ. The role of the TGF-β family in wound healing, burns and scarring: a review[J]. Int J Burns Trauma, 2012, 2(1): 18-28.
[45]	Le M, Naridze R, Morrison J, et al. Transforming growth factor Beta 3 is required for excisional wound repair in vivo[J]. PLoS One, 2012, 7(10): e48040.
[46]	Occleston NL, OKane S, Laverty HG, et al. Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarring[J]. Wound Repair Regen, 2011, 19(1): s38-s48.
[47]	Sato M, Muragaki Y, Saika S, et al. Targeted disruption of TGFβ1/Smad3 signalling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction[J]. J Clin Invest, 2003, 112(10)：1486-1494.
[48]	Zubair M, Ahmad J. Role of growth factors and cytokines in diabetic foot ulcer healing: a detailed review[J]. Rev Endocr Metab Disord, 2019, 20(2)：207-217.
[49]	Martino MM, Briquez PS, Guc E, et al. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing[J]. Science, 2014, 343(6173): 885-888.
[50]	White MJV, Briquez PS, White DAV, et al. VEGF-A, PDGF-BB and HB-EGF engineered for promiscuous super affinity to the extracellular matrix improve wound healing in a model of type 1 diabetes[J]. NPJ Regen Med, 2021, 6(1): 76.
[51]	韩春茂，程飚．皮肤创面外用生长因子的临床指南[J]．中华烧伤杂志，2017, 33(12): 721-727.

Please choose a citation manager

Content to export